Results for tag: "Meniscus Tear Drug"

The Meniscus Tear Drug market is a subset of the Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat meniscus tears, which are injuries to the cartilage in the knee joint. These drugs are used to reduce pain, swelling, and inflammation, and to promote healing. They may be administered orally, topically, or through injection. Commonly used drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and hyaluronic acid. The Meniscus Tear Drug market is highly competitive, with many companies offering products. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and Sanofi. Other companies include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more